SAN FRANCISCO -- Moderna announced people may need a second booster to increase protection. But is a fourth shot the right approach? ABC7 News reporter Luz Pena from San Francisco spoke to multiple ...
The director of the National Institutes of Health (NIH) reported favorable efficacy results after an interim analysis of data from the COVE Phase 3 efficacy trial of mRNA-1273, the messenger RNA ...
WASHINGTON -- Moderna submitted its application to the U.S. Food and Drug Administration for emergency use authorization of its updated COVID-19 vaccine booster for use in people age 18 and older, the ...
The U.S. Food and Drug Administration has approved Moderna's next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator ...